- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Podcast: Implementing a Low Dose Mammography Solution
Raymond Tu, MD, discusses the considerations for implementing a new lower dose mammography system, including patient safety, market share, and cost.
[[{"type":"media","view_mode":"media_crop","fid":"11562","attributes":{"alt":"","class":"media-image media-image-left","id":"media_crop_9305716539806","media_crop_h":"0","media_crop_image_style":"-1","media_crop_instance":"205","media_crop_rotate":"0","media_crop_scale_h":"0","media_crop_scale_w":"0","media_crop_w":"0","media_crop_x":"0","media_crop_y":"0","style":"margin: 5px; float: left;","title":" ","typeof":"foaf:Image"}}]]When United Medical Center in Washington, D.C., upgraded their film-screen mammography system, they had several factors to consider, including how to best meet the needs of their underserved patient population while keeping costs in mind.
The push to lower radiation dose was also a major factor, said Raymond Tu, chairman of the Radiology Department at UMC and president of the American College of Radiology's Washington, D.C., chapter. In this podcast, Tu discusses why UMC opted for Philips’ MicroDose Mammography system, which the company launched in North America last fall.
Here, Tu details:
• The unique needs of his patient population, and how that factored into the selection of a new technology,
• The desire to select a solution that would help the group’s market share in the area, and
• The constraining factors keeping the industry from doing more to implement lower dose technologies.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
